Secord, A. A., Lee, E., Sundborg, M., Black, D., Starks, D., Alvarez, E., … Marth, C. (2025). A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL TO COMPARE RINATABART SESUTECAN VERSUS INVESTIGATOR'S CHOICE OF CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER: RAINFOL™-02 (ENGOT-OV86/GOG-3107). In International Journal of Gynecological Cancer (Vol. 35, pp. 102614–102614). Elsevier BV. https://doi.org/10.1016/j.ijgc.2025.102614

Secord, Angeles Alvarez, Elizabeth Lee, Michael Sundborg, Destin Black, David Starks, Edwin Alvarez, David Spigel, et al. “A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL TO COMPARE RINATABART SESUTECAN VERSUS INVESTIGATOR'S CHOICE OF CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER: RAINFOL™-02 (ENGOT-OV86/GOG-3107).” In International Journal of Gynecological Cancer, 35:102614–102614. Elsevier BV, 2025. https://doi.org/10.1016/j.ijgc.2025.102614.

Secord AA, Lee E, Sundborg M, Black D, Starks D, Alvarez E, et al. A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL TO COMPARE RINATABART SESUTECAN VERSUS INVESTIGATOR'S CHOICE OF CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER: RAINFOL™-02 (ENGOT-OV86/GOG-3107). In: International Journal of Gynecological Cancer. Elsevier BV; 2025. p. 102614–102614.

Secord, Angeles Alvarez, et al. “A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL TO COMPARE RINATABART SESUTECAN VERSUS INVESTIGATOR'S CHOICE OF CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER: RAINFOL™-02 (ENGOT-OV86/GOG-3107).” International Journal of Gynecological Cancer, vol. 35, no. 11, Elsevier BV, 2025, pp. 102614–102614. Crossref, doi:10.1016/j.ijgc.2025.102614.

Secord AA, Lee E, Sundborg M, Black D, Starks D, Alvarez E, Spigel D, Cloven N, Knowles L, Melnyk A, Iii WW, Mccollum M, Lim P, Neff R, O’Malley D, Hilpert F, Klasa-Mazurkiewicz D, Varela MQ, Gladieff L, Manning-Geist B, Pothuri B, Soumaoro I, Liu Y, Marth C. A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL TO COMPARE RINATABART SESUTECAN VERSUS INVESTIGATOR'S CHOICE OF CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER: RAINFOL™-02 (ENGOT-OV86/GOG-3107). International Journal of Gynecological Cancer. Elsevier BV; 2025. p. 102614–102614.